
Europe’s competition regulators are looking at German software giant SAP, as irritation grows among multinational companies over its market power in widely used corporate planning software, reported Politico.
SAP, Germany’s most valuable company, is the leader in the market for “enterprise resource planning” (ERP) software, tools used by virtually all large businesses to manage core data on everything from cash to supplies to purchasing orders. That makes SAP just the sort of company that EU policymakers want to back as a “European champion” to be a strong competitor globally.
But users are complaining that SAP is abusing its dominance of the market to try to lock in clients and lock out competitors.
The European Commission and the German competition authority are looking into concerns that SAP is hindering users of its ERP software from switching to other vendors or connecting to competitors’ applications. Many of the world’s largest companies rely on SAP’s ERP tool, which integrates applications for managing and connecting key business processes.
The criticism in Germany is channeled through Voice, an association of IT users whose 400 members include companies such as Siemens, Adidas, and Volkswagen.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas